Table 1.
CaMKI | CaMKII | CaMKIV | |
---|---|---|---|
Structure | Monomeric (∼40 kDa) | Oligomeric (∼550 kDa) (subunit=50–60 kDa) | Monomeric (∼60 kDa) |
Distribution | |||
Tissue | Ubiquitous | Ubiquitous, abundant in brain | Limited (abundant in brain and thymus) |
Subcellular | Cytosol | PSD and cytosol | Nucleus |
Substrates | Synapsin I, CFTR, CREB, Numb, Numbl and others | Tyrosine hydroxylase, tryptophan hydroxylase, synapsin I, GluR1, glycogen synthase, MAP2, phospholamban and others | Synapsin I, MAP2, myelin basic protein, Rap-1b, CREB, SRF, MEF2, ATF1/2 and others |
Physiological roles | Transcription, cell-cycle regulation | Carbohydrate metabolism, neurotransmitter synthesis/release, transcription, cytoskeletal organization, LTP, neuronal memory, cardiac functions and others | Transcription, spermatogenesis, LTP, neuronal memory, mitochondrial biogenesis, osteogenesis and others |
Diseases in which the kinase may be involved | Cancer | Learning disorder, Angelman's syndrome, Parkinson's disease, Alzheimer's disease, delayed neuronal death, cardiac hypertrophy, arrhythmia, cardiomyocyte apoptosis, diabetes, cancer | Learning disorder, delayed neuronal death, cardiac hypertrophy, osteoporosis |
Inhibitors | KN-62, CaMKI (294–321), KN-93 | CaMKII (281–309), CaMKII (273–302), KN-62, KN-93, AIP, AC3-I, CaMKIIN, CN21, PEP-19 | KN-62, KN-93 |
Activation mechanism | Activated upon phosphorylation by CaMKK on Thr-177 located in activation loop | Activated upon autophosphorylation on Thr-286 located in autoinhibitory domain | Activated upon phosphorylation by CaMKK on Thr-196 located in activation loop |
Dephosphorylating protein phosphatase | PP2A, CaMKP, CaMKP-N | PP1, PP2A, PP2C, CaMKP, CaMKP-N | PP1, PP2A, PP2B, PP2C, CaMKP, CaMKP-N |
Abbreviations: AIP, autocamtide-2-related inhibitory peptide; ATF, activating transcription factor; CaMK, Ca2+/calmodulin-dependent protein kinase; CaMKK, CaMK kinase; CaMKP, CaMK phosphatase; CFTR, cystic fibrosis transmembrane conductance regulator; CREB, cAMP response element-binding protein; LTP, long-term potentiation; MAP2, microtubule associated protein 2; MEF2, myocyte enhancer factor 2; PP, protein phosphatase; PSD, postsynaptic density; SRF, serum response factor.
Adapted from Ishida et al. (2003).